- Fellowship - Yale University School of Medicine (1970-1971), Liver Disease
- Residency - Johns Hopkins Hospital (1965-1970), Internal Medicine
- Internship - Johns Hopkins Hospital (1964-1965), Internal Medicine
- Medical School - Johns Hopkins University School of Medicine
Willis Maddrey, M.D.
- Adelyn and Edmund M. Hoffman Distinguished Chair in Medical Science
- Arnold N. and Carol S. Ablon Professorship in Biomedical Science
- Internal Medicine - Digestive & Liver Diseases
- Liver Disease
- Liver Transplant Medicine
Willis C. Maddrey, MD, is Professor of Internal Medicine and Assistant to the President at The University of Texas Southwestern Medical Center at Dallas. Dr. Maddrey received his medical degree from The Johns Hopkins University School of Medicine in Baltimore, Maryland, and completed his residency on the Osler Medical Service of The Johns Hopkins Hospital. He was Chief Medical Resident in 1969. Additional postgraduate work includes a fellowship in liver disease with Dr. Gerald Klatskin at Yale University School of Medicine. From 1970 to 1981 Dr. Maddrey directed the liver unit at The Johns Hopkins University School of Medicine where he was Professor of Medicine and Associate Physician in Chief. From 1982 to 1990 he was Magee Professor and Chairman of the Department of Medicine at Jefferson Medical College. Dr. Maddrey has authored numerous scientific publications. He has published extensively in the areas of chronic viral hepatitis, drug-induced liver disease, alcohol-induced liver disease, liver transplantation, and primary biliary cirrhosis. He has authored numerous publications focusing on hepatitis and liver disease. He has edited or co-edited nine books including Transplantation of the Liver which is now in its third edition, and Schiff's Diseases of the Liver, now in its ninth edition. Dr. Maddrey is a member of several societies including the American Society for Clinical Investigation and the American Gastroenterological Association. He was President of the American Association for the Study of Liver Diseases in 1981. He is a Master of the American College of Physicians and served as President of the American College of Physicians in 1992-93. He is also a Fellow of the Royal College of Physicians of London, the Royal College of Physicians of Glasgow, and the Royal Australasian College of Physicians and Surgeons. Dr. Maddrey was named the Adelyn and Edmund M. Hoffman Distinguished Chair in Medical Science in 1998. Dr. Maddrey was awarded the George Stuart Outstanding Teacher Award at The Johns Hopkins University School of Medicine and the Christian R. and Mary F. Lindback Award for distinguished teaching in the clinical sciences at Jefferson Medical College in 1986. He received the Distinguished Service Citation from Wake Forest University in 1991, and was awarded the Distinguished Educator Award by the American Gastroenterological Association in 1998. He was awarded the Distinguished Service Award of the American Association for the Study of Liver Diseases in 2000.
- American Gastroenterological Association
- American College of Physicians
- American Association for the Study of Liver Diseases
- Johns Hopkins University School of Medicine 2009, The Johns Hopkins University School of Medicine Distinguished Alumnus Awards
- American College of Physicians 1992, President American College of Physicians
- American Gastroenterological Association 1998, American Gastroenterological Association Distinguished Educator Award
- American Association for the Study of Liver Diseases 1981, President American Association for the Study of Liver Diseases
Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients.
Maddrey WC Seminars in liver disease 1999 19 Suppl 1 67-75
Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure.
Zimmerman HJ, Maddrey WC Hepatology (Baltimore, Md.) 1995 Sep 22 3 767-73
Alcohol-induced liver disease.
Maddrey WC Clinics in liver disease 2000 Feb 4 1 115-31, vii
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.
Mathurin P, Mendenhall CL, Carithers RL, Ramond MJ, Maddrey WC, Garstide P, Rueff B, Naveau S, Chaput JC, Poynard T Journal of hepatology 2002 Apr 36 4 480-7
Update in hepatology.
Maddrey WC Annals of internal medicine 2001 Feb 134 3 216-23
Bioartificial liver in the treatment of hepatic failure.
Maddrey WC Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2000 Jul 4 Suppl 1 S27-30
- Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients.
- Liver Disease
- Liver Transplant Medicine